 |
|
Transketolase Activity in Uremia
Edmund T. Lonergan, MD;
Martin Semar, MS;
Kurt Lange, MD
Arch Intern Med. 1970;126(5):851-854.
Abstract
| |
Erythrocyte transketolase activity (ETKA) was determined in ten uremics undergoing long-term hemodialysis and in four patients treated with Giordano-Giovanetti diet therapy. Transketolase is an essential enzyme in the pentose phosphate shunt and plays a role in myelin sheath maintenance. Its co-factor is thiamine pyrophosphate. In thiamine deficient states ETKA is depressed. ETKA predialysis was depressed in six chronic uremics, although all received thiamine. Dialysis restored ETKA toward normal. Diet patients had depressed transketolase activity which was not affected by diet therapy despite reduced blood urea nitrogen levels. Uremic plasma inhibited normal ETKA by an average of 31.2%; inhibition was reversed by dialysis. A low weight molecular fraction (<500) obtained from dialysates of uremic subjects inhibited normal ETKA. Low weight dialyzable toxin(s) accumulates in the plasma of uremics, which inhibits ETKA and may play a role in the development of uremic polyneuropathy.
Author Affiliations
New York
From the Renal Service and Laboratory, Departments of Medicine and Pediatrics, New York Medical College, New York.
Footnotes
Received for publication July 8, 1970; accepted Aug 12.
Read before the session entitled "Protein Metabolism" (Carmelo Giordano, MD, chairman) of the Symposium on Uremic Toxins sponsored by the National Institute of Arthritis and Metabolic Diseases, Monterey, Calif, March 19, 1970.
Reprint requests to the Renal Service and Laboratory, Departments of Medicine and Pediatrics, New York Medical College, New York 10029 (Dr. Lange).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Observations on Decreased Serum Glutamic Oxalacetic Transaminase (SGOT) Activity in Azotemic Patients
COHEN et al.
ANN INTERN MED 1976;84:275-280.
ABSTRACT
|
